Neuren Pharmaceuticals Limited is a biopharmaceutical company developing therapies for neurodevelopmental disorders, including Rett syndrome and Fragile X syndrome.
Ticker code: ASX:NEU
Sector: Healthcare | Industry: Biotechnology | Website: https://www.neurenpharma.com
Market Information
| Market Capitalisation | Enterprise Value | Shares Outstanding | Free Float [%] | Free Float Value |
|---|---|---|---|---|
| $2,538,429,048 | $2,215,151,360 | 126290000 | 84.71 | $2,150,224,455 |
Balance Sheet & Quality
| Equity | Cash | Debt | Return On Equity (ROE) | EBITDA 24 Margin [%] | Net Debt / Equity [%] | Rule of 40 |
|---|---|---|---|---|---|---|
| $327,975,109 | $299,536,992 | $0 | 64.5 | 82.3 | -91.3 | 13.6 |
Technicals & Short Data
| 3EMA Status | Volatility [%] | Value Traded Today | Average Daily Liquidity | Short [%] | Days To Cover |
|---|---|---|---|---|---|
| Positive | 3.7 | $14,469,528 | $11,058,478 | 4.65 | 10.7 |
Dividends
| Previous Dividend | Last Dividend | Franking [%] | Ex-Div Date | Gross Yield [%] |
|---|---|---|---|---|
| None | None | None | None | 0.0 |
Price Performance Snapshot
| Last Traded Price | Change [%] | 1 Week [%] | 1 Month [%] | 3 Months [%] | 6 Months [%] | 12 Months [%] |
|---|---|---|---|---|---|---|
| $20.100 | -0.5 | 5.8 | 14.1 | 44.6 | 72.1 | 46.1 |
ASX:NEU Price Chart with Volume and 3EMA
ASX:NEU Short Positions
Click HERE to understand why the above moving averages have been chosen.